Why HealthEquity Stock Sank This Week

HealthEquity (HQY) dropped 8.6% this week after investors rejected the company's cautious outlook despite a fiscal second-quarter earnings beat. The health savings account provider reported adjusted earnings per share of $1.24 and revenue of $350.7 million, both topping analyst estimates.

Management's muted guidance triggered the selloff. The company lifted its full-year revenue forecast only marginally and left its adjusted EPS outlook unchanged, falling short of the Street's expectation for a more robust raise following the strong quarter.

The reaction underscores a familiar pattern in post-earnings trading: beats alone don't move stock prices when forward guidance disappoints. HQY's results demonstrated solid execution in the current quarter, but traders focused on management's refusal to signal accelerating momentum ahead. The 8.6% weekly decline erased any benefit from the Q2 outperformance.